Dr. Rauful Alam
Founder and Director
Staff Scientist, Center for Chemical Biology and Therapeutics, The University of Chicago
Chicago, United States
Synthetic organic chemist with industry drug-discovery experience, and a core contributor to PTC518 (votoplam), now in Phase III trials for Huntington's disease. He founded Chem2Cure to connect global drug-discovery practice with the next generation of Bangladeshi chemists.